Hematologic Malignancies

Panel 09 - Is 70 the new 50? Using radiation therapy to improve outcome in older patients with lymphoma

9/16/2019
4:15 PM - 5:30 PM
Location: Room W184

Session Type: Panel
1.25 AMA PRA Category 1 Credits™
1.25 CAMPEP Credits
1.5 MDCB Credits

This panel will address: 1. The demographic changes and the consequences for the incidence and age distribution of different lymphoma subtypes. The paucity of data on the treatment of older patients from controlled trials. 2. The role of RT in the treatment of older patients with aggressive and indolent lymphomas, and future prospects. 3. The role of RT in the treatment of older patients with Hodgkin lymphoma, and future prospects. 4. The spectrum of late effects of treatment (both systemic and RT) that may influence the choice of primary treatment.

Learning Objectives:

Presentations:

Lena Specht, MD, PhD

Rigshospitalet

Disclosure:
Employment
Rigshospitalet: University of Copenhagen: Employee

Compensation
Kyowa Kirin: Advisory Board;
Merck Serono: Travel Expenses: Relationship ended 12/01/2018;
MSD: Advisory Board: Travel Expenses; Takeda: Advisory Board;
Varian: Research Grants

Leadership
Danish Hodgkin Lymphoma Group: Chairman; Danish Lymphoma Proton Therapy Group: Chairman; International Lymphoma Radiation Oncology Group: Vice President

Biography:
Professor Lena Specht is Professor of Oncology at the University of Copenhagen, Denmark. She completed her training in Clinical Oncology at the University Hospital in Copenhagen. She held a research fellowship for three years at the Danish Cancer Society, and she obtained her PhD degree with work on prognostic factors in Hodgkin lymphoma.
Professor Specht is Chief Oncologist at the Department of Oncology at Rigshospitalet, University of Copenhagen. Her main areas of research and clinical interest are lymphomas and head & neck cancer. She is author of over 260 research articles and educational papers, including ILROG guidelines on lymphoma radiation therapy and ESMO guidelines on peripheral T-cell lymphomas and cutaneous lymphomas. She has authored two textbooks and numerous book chapters. She leads a Multidisciplinary Radiotherapy Research Group, comprising physicians, physicists, and civil engineers, and she has supervised 17 PhD projects and numerous post doc, postgraduate, and pregraduate projects. She is Editor of the Cochrane Haematological Malignancies Group and member of the Advisory Board for Acta Oncologica. She is Chairman of the Danish Hodgkin Lymphoma Group and the Danish Lymphoma Proton Therapy Group, and she is Vice President of the International Lymphoma Radiation Oncology Group (ILROG). She has given over 120 invited lectures worldwide, and she is Course Director for the ESTRO-ILROG School Course on Haematological Malignancies.

Presentation(s):

Send Email for Lena Specht


Assets

Panel 09 - Is 70 the new 50? Using radiation therapy to improve outcome in older patients with lymphoma



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Panel 09 - Is 70 the new 50? Using radiation therapy to improve outcome in older patients with lymphoma